Sunday 10 November 2024

Navigating the Inheritance Maze: Your Guide to Probate, Will Disputes, and Estate Challenges

Top 5 This Week

Related Posts

Apple to Offer Watches Without Blood-Oxygen Monitoring Feature

Apple Inc. to Sell Watches Without Blood Oxygen Feature Following Legal Setback

In a surprising turn of events, Apple Inc. has announced that it will be selling versions of its Series 9 and Ultra 2 watches without a blood oxygen feature in the U.S. This decision comes after a legal setback in a patent dispute with Masimo Corp.

The company revealed that the modified models will be available for purchase starting Thursday both in their retail outlets and online store. While the new watches will still include the blood oxygen monitoring tool, it will not be functional.

This move comes after the U.S. Court of Appeals for the Federal Circuit denied Apple’s request for a longer pause on an import ban imposed by the U.S. International Trade Commission. As a result, Apple will have to stop selling the watches with the oxygen measurement feature while the appeal process continues, which the company believes could last for a year or more.

Apple’s decision to remove a key feature from its devices is a rare one, but necessary to comply with the ruling. The company expressed its disagreement with the USITC decision and stated that the appeal is ongoing.

Masimo Corp. saw a 2.1% increase in its shares following the court’s decision, with CEO Joe Kiani calling it a “victory for the integrity of the American patent system.” He emphasized the importance of respecting intellectual rights and dealing with the consequences of patent infringement.

The legal battle has put one of Apple’s major revenue sources at risk, as the watches are a significant part of the company’s wearables, home, and accessories division. The ITC ruled last year that Apple’s watches violated patents related to blood oxygen measurement, leading to the temporary halt in sales.

Despite the challenges, Apple remains optimistic about the outcome of the appeal and continues to prioritize customer access to their products. The company highlighted that the feature will still be available on models sold outside the U.S. and on previously purchased watches.

The case between Apple and Masimo is ongoing, with the US Court of Appeals for the Federal Circuit overseeing the proceedings. The outcome of the appeal will have significant implications for both companies and the wearable technology market as a whole.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Popular Articles